Verona Pharma Plc ADR (NASDAQ: VRNA) kicked off on Tuesday, up 3.23% from the previous trading day, before settling in for the closing price of $60.07. Over the past 52 weeks, VRNA has traded in a range of $11.39-$70.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -39.77% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 130.04%. With a float of $74.18 million, this company’s outstanding shares have now reached $84.63 million.
In an organization with 209 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 92.63%, operating margin of -365.87%, and the pretax margin is -389.38%.
Verona Pharma Plc ADR (VRNA) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Verona Pharma Plc ADR is 12.34%, while institutional ownership is 69.87%. The most recent insider transaction that took place on Mar 12 ’25, was worth 661,942. In this transaction Chief Medical Officer of this company sold 79,264 shares at a rate of $8.35, taking the stock ownership to the 2,608,976 shares. Before that another transaction happened on Mar 12 ’25, when Company’s Officer proposed sale 9,908 for $62.70, making the entire transaction worth $621,232.
Verona Pharma Plc ADR (VRNA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 130.04% per share during the next fiscal year.
Verona Pharma Plc ADR (NASDAQ: VRNA) Trading Performance Indicators
Take a look at Verona Pharma Plc ADR’s (VRNA) current performance indicators. Last quarter, stock had a quick ratio of 10.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 124.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.16, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach 0.57 in one year’s time.
Technical Analysis of Verona Pharma Plc ADR (VRNA)
Let’s dig in a bit further. During the last 5-days, its volume was 0.79 million. That was inferior than the volume of 1.45 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 93.43%. Additionally, its Average True Range was 3.81.
During the past 100 days, Verona Pharma Plc ADR’s (VRNA) raw stochastic average was set at 73.74%, which indicates a significant decrease from 99.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.89% in the past 14 days, which was higher than the 57.08% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $62.53, while its 200-day Moving Average is $41.92. However, in the short run, Verona Pharma Plc ADR’s stock first resistance to watch stands at $62.87. Second resistance stands at $63.73. The third major resistance level sits at $65.32. If the price goes on to break the first support level at $60.42, it is likely to go to the next support level at $58.83. Assuming the price breaks the second support level, the third support level stands at $57.97.
Verona Pharma Plc ADR (NASDAQ: VRNA) Key Stats
The company with the Market Capitalisation of 5.25 billion has total of 80,820K Shares Outstanding. Its annual sales at the moment are 42,280 K in contrast with the sum of -173,420 K annual income. Company’s last quarter sales were recorded 36,660 K and last quarter income was -33,830 K.
